Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02615886 · ClinicalTrials.gov registry record · NA

Pilot Feasibility of Rice Bran Supplementation in Nicaraguan Children

A NA study, sponsored by Colorado State University.

Completed
Registry status
NA
Development phase
47
Enrollment target

NCT02615886: Completed NA study, sponsored by Colorado State University.

NCT02615886 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 47 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02615886, a NA study, has completed, sponsored by Colorado State University.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target

Study Summary

The purpose is to assess feasibility of rice bran consumption in weaning children and collect pilot data on gut microbiome and metabolome modulation with rice bran intake for diarrheal prevention.

Primary Outcome

Record daily rice bran consumption and track compliance to diet intervention by regular visits from local study personnel.

Interventions

  • DIETARY_SUPPLEMENT Rice bran
  • OTHER Observational Control

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2014-11
Est. Completion 2015-10
Phase NA
Colorado State University

94 total trials

What the finished NCT02615886 record still lists

NCT02615886 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Rice bran is the first listed.

NCT02615886 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02615886 about?

NCT02615886 is a clinical study titled "Pilot Feasibility of Rice Bran Supplementation in Nicaraguan Children". The purpose is to assess feasibility of rice bran consumption in weaning children and collect pilot data on gut microbiome and metabolome modulation with rice bran intake for diarrheal prevention.

What is the current status of trial NCT02615886?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2014-11. Estimated completion is 2015-10.

What interventions are being tested in trial NCT02615886?

The interventions under investigation include: Rice bran (DIETARY_SUPPLEMENT), Observational Control (OTHER).

Who is sponsoring clinical trial NCT02615886?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02615886's enrollment target sits among peer trials

47 1400th of 2000 higher than 599 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02615886, the US trial registry maintained by the National Library of Medicine. NCT02615886 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.